ABSORPTION OF CIPROFLOXACIN ADMINISTERED THROUGH A NASOGASTRIC OR A NASODUODENAL TUBE IN VOLUNTEERS AND PATIENTS RECEIVING ENTERAL NUTRITION

被引：18
作者：
YUK, JH
NIGHTINGALE, CH
QUINTILIANI, R
YESTON, NS
ORLANDO, R
DOBKIN, ED
KAMBE, JC
SWEENEY, KR
BUONPANE, EA
机构：
[1] HARTFORD HOSP, DEPT PHARM, HARTFORD, CT 06115 USA
[2] HARTFORD HOSP, DEPT INFECT DIS, HARTFORD, CT 06115 USA
[3] HARTFORD HOSP, DEPT CRIT CARE MED, HARTFORD, CT 06115 USA
[4] UNIV CONNECTICUT, SCH PHARM, FARMINGTON, CT 06032 USA
[5] SCH MED FARMINGTON, FARMINGTON, CT USA
来源：
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 1990年 / 13卷 / 02期
关键词：
D O I：
10.1016/0732-8893(90)90092-A
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：99 / 102
页数：4
相关论文
共 15 条
[1]  
ASHBY J, 1985, J ANTIMICROB CHEMOTH, V16, P805
[2]   PHARMACOKINETICS OF CIPROFLOXACIN AFTER INTRAVENOUS AND INCREASING ORAL DOSES [J].
BERGAN, T ;
THORSTEINSSON, SB ;
KOLSTAD, IM ;
JOHNSEN, S .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1986, 5 (02) :187-192
[3]   PHARMACOKINETICS OF CIPROFLOXACIN IN HEALTHY-VOLUNTEERS AFTER ORAL AND INTRAVENOUS ADMINISTRATION [J].
BORNER, K ;
HOFFKEN, G ;
LODE, H ;
KOEPPE, P ;
PRINZING, C ;
GLATZEL, P ;
WILEY, R ;
OLSCHEWSKI, P ;
SIEVERS, B ;
REINITZ, D .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1986, 5 (02) :179-186
[4]   PHARMACOKINETICS OF 3 ORAL FORMULATIONS OF CIPROFLOXACIN [J].
DAVIS, RL ;
KOUP, JR ;
WILLIAMSWARREN, J ;
WEBER, A ;
SMITH, AL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 28 (01) :74-77
[5]   SHOULD CLEARANCE BE NORMALIZED TO BODY-SURFACE OR TO LEAN BODY-MASS [J].
HALLYNCK, TH ;
SOEP, HH ;
THOMIS, JA ;
BOELAERT, J ;
DANEELS, R ;
DETTLI, L .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 11 (05) :523-526
[6]   REDUCED ENTERAL ABSORPTION OF CIPROFLOXACIN IN THE PRESENCE OF ANTACIDS [J].
HOFFKEN, G ;
BORNER, K ;
GLATZEL, PD ;
KOEPPE, P ;
LODE, H .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1985, 4 (03) :345-345
[7]   CIPROFLOXACIN BILIARY DISPOSITION IN CHOLECYSTECTOMIZED PATIENTS WITH SPECIAL REFERENCES TO HPLC AND BIOASSAY DATA [J].
JEHL, F ;
ADLOFF, M ;
MONTEIL, H ;
BROGARD, JM .
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1987, 12 (02) :115-122
[8]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR DETERMINATION OF CIPROFLOXACIN IN BIOLOGICAL-FLUIDS [J].
JEHL, F ;
GALLION, C ;
DEBS, J ;
BROGARD, JM ;
MONTEIL, H ;
MINCK, R .
JOURNAL OF CHROMATOGRAPHY, 1985, 339 (02) :347-357
[9]   SUCRALFATE REDUCES THE GASTROINTESTINAL ABSORPTION OF NORFLOXACIN [J].
PARPIA, SH ;
NIX, DE ;
HEJMANOWSKI, LG ;
GOLDSTEIN, HR ;
WILTON, JH ;
SCHENTAG, JJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (01) :99-102
[10]   EFFECT OF DOSE SIZE ON BIOAVAILABILITY OF CIPROFLOXACIN [J].
PLAISANCE, KI ;
DRUSANO, GL ;
FORREST, A ;
BUSTAMANTE, CI ;
STANDIFORD, HC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (06) :956-958
12